Relay Therapeutics, Inc. (RLAY)
$19.76+1.65%Close
BUYBULL · day 11
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $3.5B
- Avg volume
- 3.6M
- Beta
- 1.70
- P/E (TTM)
- -12.59
- Short % float
- 29.57%
- Days to cover
- 17.4
- SI change
- -5.4%
- 1W
- -4.40%
- 1M
- +7.16%
- 3M
- +46.05%
- YTD
- +141.56%
- vs SPY 1W
- -3.21%
- vs SPY 1M
- +3.84%
- vs SPY 3M
- +43.65%
- vs SPY YTD
- +129.81%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
- IMCCSELLIM Cannabis Corp.CRISISQ -22$0.11+0.00%
Industry peers
FMP comparable companies · ranked by market cap
- AMLXBUYAmylyx Pharmaceuticals, Inc.$4.3BRECOVERYQ 10$38.66-1.32%
- NKTRBUYNektar Therapeutics$2.1BRECOVERYQ 13$74.02-0.45%
- ZBIOSELLZenas BioPharma, Inc.$2.0BRECOVERYQ 20$32.29-1.98%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.7BRECOVERYQ 18$19.65-0.41%
- INBXBUYInhibrx Biosciences Inc.$1.5BRECOVERYQ 33$103.63+1.26%
- ORICBUYORIC Pharmaceuticals, Inc.$1.5BBULLQ 4$14.20-5.21%
- IMTXSELLImmatics N.V.$1.2BCRISISQ 8$8.93-2.69%
- SANABUYSana Biotechnology, Inc.$1.1BRECOVERYQ -4$3.91-3.32%
- CVACCureVac N.V.$1.0B$4.66
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 3
- GROWTH
- 4
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-25.4%
REV YoY-
ROE-42.3%
EPS YoY-
ROA-29.6%
GROSS-567
OP-2999
NET-2764
[VALUATION]
P/E TTM-12.59
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B4.50
P/FCF-
EV/EBITDA-14.78
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E3.44
ALTMAN Z-
CURR RATIO18.27
ND/EBITDA-
BETA1.70
